Dexamethasone as a Treatment of COVID-19

Dexamethasone as a Treatment of COVID-19

Saved in:

Bibliographic Details
Main Authors:	Abdullah Alkattan, Mahmoud Kandeel
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2021-01-01
Series:	Dr. Sulaiman Al Habib Medical Journal
Subjects:	covid-19 sars-cov-2 cytokine storm dexamethasone
Online Access:	https://journals.lww.com/10.2991/dsahmj.k.201125.001
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

MECHANISMS OF CYTOKINE STORM DEVELOPMENT IN COVID-19 AND NEW POTENTIAL TARGETS OF PHARMACOTHERAPY
by: V. I. Petrov, et al.
Published: (2021-05-01)

Exploring pentoxifylline as an alternative treatment for dexamethasone in diabetic patients with COVID-19: a randomized controlled trial
by: Mohsen Gholinataj Jelodar, et al.
Published: (2025-07-01)

Treatment Options during Cytokine Storm
by: Abdullah Alkattan, et al.
Published: (2021-04-01)

Breakthrough Infection and Death after COVID-19 Vaccination: A Physics Perspective
by: Seyed Ali Reza Mortazavi, et al.
Published: (2025-06-01)

Hyperglycemia and possible mechanisms of β-cell damage in patients with COVID-19
by: Z. A. Kalmykova, et al.
Published: (2020-08-01)

A retrospective evaluation of COVID-19 patients treated with Tocilizumab: who should be treated?
by: Semiha Çelik Ekinci, et al.
Published: (2021-12-01)

Comparative analysis of immunosuppressive therapy effectiveness in COVID-19 patients
by: Anton V. Tyurin, et al.
Published: (2022-09-01)

Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors
by: Huan Han, et al.
Published: (2020-01-01)

Neuropilin‐1 as a Neuroinflammatory Entry Factor for SARS‐CoV‐2 Is Attenuated in Vaccinated COVID‐19 Patients: A Case–Control Study
by: Faezeh Hosseini, et al.
Published: (2025-04-01)

Efficacy of sarilumab and dexamethasone co-administration for lowering multiple blood biomarkers in the treatment of cytokine release syndrome in hospitalized covid-19 patients
by: Ishtiaq Ahmad, et al.
Published: (2024-06-01)

Dexamethasone, dexamethasone + remdesivir in treating moderate to severe COVID-19: retrospective observational cohort study
by: Nithish Sattoju, et al.
Published: (2023-07-01)

CD147-high classical monocytes: a cellular biomarker for COVID-19 disease severity and treatment response
by: Teruaki Murakami, et al.
Published: (2025-04-01)

A perfect storm: the deadly intersection of sickle cell disease and COVID-19
by: Arturo José Martí-Carvajal, et al.
Published: (2025-08-01)

Possibilities of Hyperinflammation Correction in COVID-19
by: I. S. Simutis, et al.
Published: (2021-06-01)

A comprehensive review and meta-analysis of the relationships between interleukin-7 levels and COVID-19 severity
by: Michal MATUSZEWSKI, et al.
Published: (2023-03-01)

Insulin-Like Growth Factor Binding Protein, Acid-Labile Subunit Serum Level During the Acute and Convalescent Stage of SARS-CoV-2 Infection Depicted in a Longitudinal Study of 72 Patients During the First Wave of Pandemic
by: Gad H, et al.
Published: (2025-06-01)

Monitoring Cytokine Levels in COVID-19 Overexposed and Vaccinated Volunteers
by: D. D. Briukhova, et al.
Published: (2023-11-01)

The Management of Cytokine Storm in COVID-19
by: Cleopas Martin Rumende, et al.
Published: (2020-10-01)

The Management of Cytokine Storm in COVID-19
by: Cleopas Martin Rumende, et al.
Published: (2020-10-01)

Incidence and risk factors of new clinical disorders in patients with COVID-19 hyperinflammatory syndrome
by: Kevin E. Duong, et al.
Published: (2025-06-01)

T-Cell Phenotypes and Systemic Cytokine Profiles of People Living with HIV Admitted to Hospital with COVID-19
by: Mieke A. van der Mescht, et al.
Published: (2024-10-01)

IMMUN RESPONSES IN COVID-19
by: Bülent Çakal
Published: (2021-04-01)

Mixed storm in SARS‐CoV‐2 infection: A narrative review and new term in the Covid‐19 era
by: Basil Mohammed Alomair, et al.
Published: (2023-04-01)

Characteristics of cytokines/chemokines associated with disease severity and adverse prognosis in COVID-19 patients
by: Jianghao Cheng, et al.
Published: (2024-11-01)

The Role of Ferritin in Assessing COVID-19 Severity
by: Yu. S. Polushin, et al.
Published: (2021-08-01)

Tocilizumab in COVID-19: A Double-Edged Sword?
by: Bartosz Kudliński, et al.
Published: (2024-12-01)

Hemoadsorption in Patients with Various Types of Respiratory Support for Severe COVID-19
by: R. E. Yakubtsevich, et al.
Published: (2022-10-01)

Dexamethasone Treatment Considerably Reduces the Levels of Some Inflammatory Cytokines, Lactate Dehydrogenase, and C-Reactive Protein in COVID-19 Pneumonia Patients With Pre-existing COPD
by: Gholamreza Sepehri, et al.
Published: (2024-10-01)

Morphofunctional characteristics of blood cells in reconvalescents after suffering COVID-19
by: S. N. Klyueva, et al.
Published: (2022-07-01)

Unclosing Clinical Criteria and the Role of Cytokines in the Pathogenesis of Persistent Post-COVID-19 Headaches: A Pilot Case-Control Study from Egypt
by: Ahmed Abualhasan, et al.
Published: (2025-01-01)

Plasma cytokines in patients with COVID-19 during acute phase of the disease and following complete recovery
by: N. A. Arsentieva, et al.
Published: (2021-05-01)

Influence of previous COVID-19 exposure and vaccine type (CoronaVac, ChAdOx1 nCov-19 or BNT162b2) on antibody and cytokine (Th1 or Th2) responses
by: Diana Lourdes Padilla-Bórquez, et al.
Published: (2024-12-01)

Pathogenesis of COVID-19: ACE2, Cytokine Storm and Extrapulmonary Manifestations
by: Abdul Muhaymin Muhaymin, et al.
Published: (2021-09-01)

Assessment of immune response in ICU admitted SARS-CoV-2 patients from Kashmir, North India
by: Iqra Farooq, et al.
Published: (2025-01-01)

Cytokine profiles and neurological manifestations in post-COVID syndrome
by: Yulia Desheva, et al.
Published: (2025-02-01)

Stability of cytokine and immunoglobulin concentrations in the general population: prepandemic basal concentrations and intraindividual changes until the COVID-19 pandemic
by: Magda Gasull, et al.
Published: (2025-07-01)

Effects of B-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
by: Al-kuraishy, Hayder M., et al.
Published: (2023)

Development and Validation of the CARRA-VID Prognostic Score: C Reactive Protein to Albumin Ratio, Red Blood Cell Distribution Width and Age-Based Score for Prognostication of Hospitalized COVID-19 Patients
by: Marko Lucijanic, et al.
Published: (2025-04-01)

New Coronavirus COVID-19 (SARS-CoV-2)
by: O. V. Shamsheva
Published: (2020-03-01)

Weathering the Storm: How Age and Biologics Influence the COVID-19 Cytokine Surge
by: Corine Astroth, et al.
Published: (2025-04-01)